One point per daily model run. The range autoscales, so a flat-looking line can still hide 1–2 point moves — read the From → To values for the actual range.
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.
argenx SE (ARGX): score, valuation & FAQ
argenx SE (ARGX) is a Biotechnology company that scores 69.6 out of 100 on the Bull Rankings quality-growth model — a solid, above-average reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.
Its strongest graded signals are Rev (A) and D/E (A).
Is ARGX a good stock to buy?
Bull Rankings scores ARGX 69.6 out of 100 on its quality-growth model, which is a solid, above-average reading. That is driven by Rev (A) and D/E (A). A score is a quantitative screen of argenx SE's fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.
Why does ARGX score 69.6 on Bull Rankings?
The quality-growth score blends three pillars — quality (returns on capital, margins, leverage, earnings quality), growth (revenue and earnings expansion), and value (valuation versus sector peers). ARGX earns its highest marks on Rev (A) and D/E (A). Each pillar is graded against sector-aware thresholds, then combined into the single 0–100 score.
Is ARGX overvalued or undervalued?
We don't compute a reliable discounted-cash-flow value for ARGX — typically because it is not yet consistently profitable or free-cash-flow positive — so its valuation rests on growth and price-to-sales rather than on earnings-based intrinsic value. Judge it on the trajectory of the business, not a single multiple.
What are the main risks of investing in ARGX?
The market is pricing growth at a lofty P/E of 38.3, and any slowdown from the current 89.6% revenue growth would expose the stock to valuation compression, especially given the Bull Rankings model’s weak Value pillar (47) and the short track‑record signal; a miss on near‑term sales would trigger a sell‑off.
New to these metrics? The guides explain free cash flow, how the score works, and more in the learn hub — or run another name through the screener.
Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial adviser.